17 documents found, page 1 of 2

Sociodemographic factors and biologic therapy exposure impacting health-related...

Funding Information: This work was supported by a research grant from the Portuguese Society of Rheumatology. Publisher Copyright: © The Author(s) 2025.; Psoriatic arthritis (PsA) is a very heterogeneous disease with significant impact on health-related quality-of-life (HRQoL). Our objective was to assess and identify predictors of HRQoL in a 3-year follow-up period among PsA patients. Patients with PsA include...

Second and third TNF inhibitors in European patients with axial spondyloarthritis

OBJECTIVE: To investigate real-world effectiveness of tumor necrosis factor inhibitors (TNFi) in patients with axial spondyloarthritis (axSpA) and the association with 1) treatment line (second and third TNFi-series) and 2) reason for withdrawal from the preceding TNFi (lack of efficacy (LOE) versus adverse events (AE)). METHODS: Prospectively collected routine care data from 12 European registries were pooled....

GIScaSpA-study of subclinical gut involvement in axial spondyloarthritis

Drug effectiveness of 2nd and 3rd TNF inhibitors in psoriatic arthritis

Funding Information: This work was supported by Novartis. Novartis had no influence on the data collection, statistical analyses, manuscript preparation or decision to submit. Publisher Copyright: © 2024 The Authors; Objective: To investigate real-world retention and remission rates in PsA patients initiating a 2nd or 3rd TNFi and the association with reason for discontinuation from the previous TNFi-treatment....

Hip involvement in Axial Spondylarthritis Patients

Effectiveness of secukinumab in radiographic and non-radiographic axial spondyl...

Funding Information: Novartis Pharma AG for supporting the EuroSpA collaboration. The paper has been presented at the Scandinavia Congress of Rheumatology 2023 as an oral presentation and at the EULAR 2023 Congress as a poster presentation (POS0656) with the following abstract: SNC, SHR, LMO, etc. Does radiographic status impact secukinumab effectiveness in European axial spondyloarthritis patients treated in r...

Creation and Validation of a Portuguese Version of the UCLA Scleroderma Clinica...

Funding: This research received no external funding. CEISUC/CIBB is funded by national funds through FCT Foundation for Science and Technology, I.P., under the Multiannual Financing of R&D Units 2020–2023.; (1) Background: The UCLA GIT 2.0 questionnaire has been recognized as a feasible and reliable instrument to assess gastrointestinal (GI) symptoms in systemic sclerosis (SSc) patients and their impact on qual...

Validation of the Portuguese Version of the Scleroderma Health Assessment Quest...

Funding Information: No funding was received for conducting this study. CEISUC/CIBB is funded by national funds through FCT, Foundation for Science and Technology, I.P., under the Multiannual Financing of R&D Units 2020–2023. Publisher Copyright: © 2023 by the authors.; The Health Assessment Questionnaire Disability Index (HAQ-DI) was completed with five visual analog scales to assess systemic sclerosis (SSc) c...

Costs of incident non-hip osteoporosis-related fractures in postmenopausal wome...

Funding Information: Open access funding provided by FCT|FCCN (b-on). The study was supported by an unrestricted research grant from Amgen. Publisher Copyright: © 2023, The Author(s).; Summary: Osteoporosis-related fractures lead to high morbidity, mortality, and healthcare costs among post-menopausal women. This study showed that incident non-hip osteoporosis-related fractures are frequent among women aged 50 ...

Costs of hip fractures in postmenopausal women in Portugal

Funding Information: The study was supported by an unrestricted research grant from Amgen.